Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a trial of IcBD-01 rectal cannabidiol enema for ulcerative colitis
MOH_2021-02-28_009803Phase 2Not yet recruiting
- Sponsor
- CannaMore Biotechs
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in autoimmune colitis comparing IcBD-01 cannabidiol enema with Placebo (2 arms). Planned start Dec 2020; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on MOH_2021-02-28_009803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-02-28_009803.